|
|
 |
|
Viewing report
|
|
|
|
North American Market for Computer-aided Detection and Diagnosis
Frost & Sullivan, June 2011, Pages: 64
This research service provides a study of the North American market for computer-aided detection and diagnosis (CAD) systems in medical imaging. The study prevents historical, base year, and forecast market metrics including revenues, market drivers and restraints, technology and competitive trends, and market share analysis. The market is analyzed according to a number of market segmentations: by solution component, by clinical segment, by customer type, and by sales channel. It provides an in-depth view of the various imaging modalities used with CAD by exploring the different clinical segments of breast, lung, colorectal, and abdominal imaging as well as other emerging segments such as neurological and musculoskeletal imaging.
This Frost & Sullivan research service titled North American Market for Computer-aided Detection and Diagnosis describes the market size and market trends as well as provides a revenue forecast. In this research, Frost & Sullivan's expert analysts thoroughly examine the following technologies: mammography computer-aided detection, radiography (X-ray, computed/digital radiography), computed tomography (CT), magnetic resonance (MR), ultrasound, tomosynthesis, and nuclear imaging.
Market Overview
Industry Push toward Quantitative Imaging Positions CAD Adequately for Renewed Clinical Expansion
Since the inception of the market in 1998 and until 2008, revenues from the North American CAD market continued to grow rapidly year over year. It surpassed the $100 million mark for the first time in 2007. However, this upward trend was reversed in 2009 due to several factors affecting global healthcare. Once confined to image analysis and pattern recognition algorithms, CAD solutions have expanded dramatically in recent years to provide more workflow management functions for the diseases and conditions they cover. “From CAD solutions used on the spot, some have evolved into computer-assisted decision-making solutions or computer-assisted pre-surgical assessment solutions, whereby they provide more of an end-to-end solution used prior, during, and after treatment or surgery and accessing databases for clinical decision support,” notes the analyst of this research service. “Applications such as prostate treatment or liver transplantation will drive CAD from a mere detection and diagnosis tool to more complete solutions providing image based analytics, disease quantification, treatment assessment, and workflow management.”
Regardless of the unfavorable market conditions prevailing in North America since 2008, CAD industry participants have continued to fuel their research and development efforts and expand their product portfolio. As a result, the market is slowly starting to move towards multi-modality solutions, a trend that is poised to broaden market appeal of CAD through numerous sales channels.
Stringent Regulatory Scenario Extends Product-Launch Timelines
Reimbursement is a key element in the business model for CAD purchases. The profitability of medical imaging service lines is being challenged as reimbursement rates for procedures continue to fall, at the rate of a few percentage points annually, due to various Medicare reimbursement cuts and healthcare reforms. In this tough economic landscape, it becomes difficult for clinicians to justify the extra cost that CAD adds to imaging procedures, without a clear financial return. The business case for CAD becomes more challenging within as well as outside mammography. As for its clinical case, it is balanced by greater clinical acceptance on one hand, and slowing technology innovation on the other.
In light of the new U.S. Food and Drug Administration (FDA) draft guidance documents for CAD technology issued in October 2009, CAD vendors will be facing a toughening regulatory environment and will be slower in bringing CAD innovation to the marketplace. “Despite imaging providers’ budgets starting to free up during the latter part of 2010, CAD has not been in the best position to return to its historical double-digit growth rate,’ says the analyst. “Current market dynamics suggest that the market will continue upon a steady, but not explosive growth path.” A careful analysis of the clinical benefits, the impact on workflow, and the return on investment (ROI) of CAD solutions will be crucial for CAD vendors to drive more favorable purchasing decisions within a widening addressable marketplace. This market reality calls for greater customer-education efforts from the vendors about CAD, as well as more effective communication and collaboration with existing and prospective customers.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
By Application Type:
- Breast CAD
- Lung CAD
- Colorectal CAD
- Abdominal CAD
- Neurological, Musculoskeletal, Cardiovascular CAD
- Technologies
The following technologies are covered in this research:
- Mammography
- Radiography (X-ray, computed/digital radiography)
- Computed tomography (CT)
- Magnetic resonance (MR)
- Ultrasound
- Tomosynthesis
- Nuclear Imaging
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
